Skip to content
Back to search

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

Techniker KrankenkasseGermanyPublished on Nov 17, 2026
41 days left

Description

The TK aims to conclude discount contracts pursuant to Section 130a(8) SGB V with all suitable pharmaceutical companies for the active substance Aflibercept (ATC: S01LA05; strength: 40 mg/ml). The contract will be concluded within the framework of the TK's Open-House procedure: Individual negotiations on contract terms will not be conducted; uniform conditions apply. The TK does not guarantee exclusivity to individual contracting partners. The contract term is a maximum of 12 months, commencing on 01.08.2026. The contract ends at the latest on 31.07.2027, regardless of the date of contract conclusion. The contract can be extended by 12 months. All further information can be found in the participation and contract documents.

CPV codes

Pharmaceutical products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders